Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$24.41 USD
+0.08 (0.33%)
Updated May 6, 2024 04:00 PM ET
After-Market: $24.40 -0.01 (-0.04%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.76 |
EPS Last Quarter | -0.09 |
Last EPS Surprise | 75.68% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.42 |
Next Year | -2.28 |
EPS (TTM) | -1.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 53.57M | 56.13M | 237.48M | 259.38M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 53.57M | 56.13M | 237.48M | 259.38M |
Low Estimate | 53.57M | 56.13M | 237.48M | 259.38M |
Year ago Sales | 50.14M | 61.49M | 219.79M | 237.48M |
Year over Year Growth Est. | 6.84% | -8.72% | 8.05% | 9.22% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.76 | -0.66 | -2.42 | -2.28 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.76 | -0.66 | -2.32 | -1.78 |
Low Estimate | -0.76 | -0.66 | -2.51 | -2.78 |
Year ago EPS | -0.70 | -0.26 | -2.14 | -2.42 |
Year over Year Growth Est. | -8.57% | -153.85% | -13.08% | 5.58% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.76 | -0.66 | -2.42 | -2.28 |
7 Days Ago | -0.76 | -0.66 | -2.42 | -2.28 |
30 Days Ago | -0.76 | -0.66 | -2.42 | -2.28 |
60 Days Ago | -0.76 | -0.66 | -3.01 | -1.78 |
90 Days Ago | -0.75 | -0.64 | -2.99 | -1.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.76 | -0.66 | -2.42 | -2.28 |
Zacks Consensus Estimate | -0.76 | -0.66 | -2.42 | -2.28 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.09 | -0.10 | -0.26 | -0.70 | NA |
Estimate | -0.37 | -0.84 | -0.92 | -1.01 | NA |
Difference | 0.28 | 0.74 | 0.66 | 0.31 | 0.50 |
Surprise | 75.68% | 88.10% | 71.74% | 30.69% | 66.55% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more